Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas.
Bunse L, Rupp AK, Poschke I, Bunse T, Lindner K, Wick A, Blobner J, Misch M, Tabatabai G, Glas M, Schnell O, Gempt J, Denk M, Reifenberger G, Bendszus M, Wuchter P, Steinbach JP, Wick W, Platten M. Bunse L, et al. Among authors: gempt j. Neurol Res Pract. 2022 May 23;4(1):20. doi: 10.1186/s42466-022-00184-x. Neurol Res Pract. 2022. PMID: 35599302 Free PMC article.
Glioma patients in outpatient care-optimization of psychosocial care in neuro-oncological patients (GLIOPT): Protocol for a cluster randomized controlled trial.
Renovanz M, Hippler M, Voss M, Wehinger J, Keßler AF, Gempt J, Nadji-Ohl M, Weiß Lucas C, Rapp M, Misch M, Coburger J, Mehlitz M, Meixensberger J, Keric N, Tabatabai G, Blettner M, Schranz M, Singer S. Renovanz M, et al. Among authors: gempt j. Trials. 2020 May 27;21(1):434. doi: 10.1186/s13063-020-04321-2. Trials. 2020. PMID: 32460811 Free PMC article.
A Continuous Correlation Between Residual Tumor Volume and Survival Recommends Maximal Safe Resection in Glioblastoma Patients: A Nomogram for Clinical Decision Making and Reference for Non-Randomized Trials.
Skardelly M, Kaltenstadler M, Behling F, Mäurer I, Schittenhelm J, Bender B, Paulsen F, Hedderich J, Renovanz M, Gempt J, Barz M, Meyer B, Tabatabai G, Tatagiba MS. Skardelly M, et al. Among authors: gempt j. Front Oncol. 2021 Dec 13;11:748691. doi: 10.3389/fonc.2021.748691. eCollection 2021. Front Oncol. 2021. PMID: 34966669 Free PMC article.
DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis.
Bernhardt D, König L, Grosu A, Wiestler B, Rieken S, Wick W, Gempt J, Krieg SM, Schmidt-Graf F, Sahm F, Meyer B, Krause BJ, Petersen C, Fietkau R, Thomas M, Giordano F, Wittig-Sauerwein A, Debus J, Tabatabai G, Hau P, Steinbach J, Combs SE; Expert Panel of the German Society of Radiation Oncology (DEGRO). Bernhardt D, et al. Among authors: gempt j. Strahlenther Onkol. 2022 Oct;198(10):873-883. doi: 10.1007/s00066-022-01994-3. Epub 2022 Aug 29. Strahlenther Onkol. 2022. PMID: 36038669 Free PMC article. Review.
DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment.
Bernhardt D, König L, Grosu AL, Rieken S, Krieg SM, Wick W, Wiestler B, Schmidt-Graf F, Sahm F, Gempt J, Meyer B, Krause BJ, Petersen C, Fietkau R, Thomas M, Giordano F, Wittig-Sauerwein A, Debus J, Tabatabai G, Hau P, Steinbach J, Combs SE; Expert Panel of the German Society of Radiation Oncology (DEGRO). Bernhardt D, et al. Among authors: gempt j. Strahlenther Onkol. 2022 Nov;198(11):971-980. doi: 10.1007/s00066-022-01973-8. Epub 2022 Aug 29. Strahlenther Onkol. 2022. PMID: 36038670 Free PMC article. Review.
Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendations.
Vogel MME, Wagner A, Gempt J, Krenzlin H, Zeyen T, Drexler R, Voss M, Nettekoven C, Abboud T, Mielke D, Rohde V, Timmer M, Goldbrunner R, Steinbach JP, Dührsen L, Westphal M, Herrlinger U, Ringel F, Meyer B, Combs SE. Vogel MME, et al. Among authors: gempt j. Sci Rep. 2023 Feb 16;13(1):2766. doi: 10.1038/s41598-023-29790-8. Sci Rep. 2023. PMID: 36797335 Free PMC article.
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.
Keric N, Krenzlin H, Kalasauskas D, Freyschlag CF, Schnell O, Misch M, von der Brelie C, Gempt J, Krigers A, Wagner A, Lange F, Mielke D, Sommer C, Brockmann MA, Meyer B, Rohde V, Vajkoczy P, Beck J, Thomé C, Ringel F. Keric N, et al. Among authors: gempt j. J Neurooncol. 2024 Mar;167(1):133-144. doi: 10.1007/s11060-024-04585-7. Epub 2024 Feb 7. J Neurooncol. 2024. PMID: 38326661 Free PMC article.
274 results